Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice

Documenti analoghi

• Targeting neutrophils: Mechanism and advances in cancer therapy
  di: Shuaixi Yang, et al.
  Pubblicazione: (2024)
• Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment
  di: Na Li, et al.
  Pubblicazione: (2025)
• Lysine‐specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti‐programmed death 1 therapy in liver cancer
  di: Chen Liang, et al.
  Pubblicazione: (2025)
• Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes
  di: Jiaqiang Xiong, et al.
  Pubblicazione: (2024)
• Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis
  di: Zhen Qin, et al.
  Pubblicazione: (2024)